American Journal of Respiratory and Critical Care Medicine

1. Mannino DM, Ford ES, Redd SC. Obstructive and restrictive lung disease and functional limitation: data from the Third National Health and Nutrition Examination. J Intern Med 2003;254:540547.
2. Mannino DM, Holguin F, Pavlin BI, Ferdinands JM. Risk factors for prevalence of and mortality related to restriction on spirometry: findings from the First National Health and Nutrition Examination Survey and follow-up. Int J Tuberc Lung Dis 2005;9:613621.
3. Scarlata S, Pedone C, Fimognari FL, Bellia V, Forastiere F, Incalzi RA. Restrictive pulmonary dysfunction at spirometry and mortality in the elderly. Respir Med 2008;102:13491354.
4. Guerra S, Sherrill DL, Venker C, Ceccato CM, Halonen M, Martinez FD. Morbidity and mortality associated with the restrictive spirometric pattern: a longitudinal study. Thorax 2010;65:499504.
5. Iyer VN, Schroeder DR, Parker KO, Hyatt RE, Scanlon PD. The nonspecific pulmonary function test: longitudinal follow-up and outcomes. Chest 2011;139:878886.
6. Mannino DM, McBurnie MA, Tan W, Kocabas A, Anto J, Vollmer WM, et al.; BOLD Collaborative Research Group. Restricted spirometry in the Burden of Lung Disease Study. Int J Tuberc Lung Dis 2012;16:14051411.
7. Meghji J, Nadeau G, Davis KJ, Wang D, Nyirenda MJ, Gordon SB, et al. Noncommunicable lung disease in Sub-Saharan Africa. A community-based cross-sectional study of adults in urban Malawi. Am J Respir Crit Care Med 2016;194:6776.
8. Backman H, Eriksson B, Hedman L, Stridsman C, Jansson S-A, Sovijärvi A, et al. Restrictive spirometric pattern in the general adult population: methods of defining the condition and consequences on prevalence. Respir Med 2016;120:116123.
9. Sood A, Petersen H, Qualls C, Meek PM, Vazquez-Guillamet R, Celli BR, et al. Spirometric variability in smokers: transitions in COPD diagnosis in a five-year longitudinal study. Respir Res 2016;17:147.
10. Siddharthan T, Grigsby M, Miele CH, Bernabe-Ortiz A, Miranda JJ, Gilman RH, et al. Prevalence and risk factors of restrictive spirometry in a cohort of Peruvian adults. Int J Tuberc Lung Dis 2017;21:10621068.
11. Wan ES, Fortis S, Regan EA, Hokanson J, Han MK, Casaburi R, et al.; COPDGene Investigators. Longitudinal phenotypes and mortality in preserved ratio impaired spirometry in the COPDGene study. Am J Respir Crit Care Med 2018;198:13971405.
12. Wijnant SRA, De Roos E, Kavousi M, Stricker BH, Terzikhan N, Lahousse L, et al. Trajectory and mortality of preserved ratio impaired spirometry: the Rotterdam Study. Eur Respir J 2020;55:1901217.
13. Marott JL, Ingebrigtsen TS, Çolak Y, Vestbo J, Lange P. Lung function trajectories leading to chronic obstructive pulmonary disease as predictors of exacerbations and mortality. Am J Respir Crit Care Med 2020;202:210218.
14. Cox P, Miller L, Petty TL. Clinical evaluation of a new electronic spirometer. Chest 1973;63:517519.
15. Løkke A, Marott JL, Mortensen J, Nordestgaard BG, Dahl M, Lange P. New Danish reference values for spirometry. Clin Respir J 2013;7:153167.
16. Helweg-Larsen K. The Danish register of causes of death. Scand J Public Health 2011;39:2629.
17. Schmidt M, Schmidt SAJ, Sandegaard JL, Ehrenstein V, Pedersen L, Sørensen HT. The Danish National Patient Registry: a review of content, data quality, and research potential. Clin Epidemiol 2015;7:449490.
18. Thomsen RW, Lange P, Hellquist B, Frausing E, Bartels PD, Krog BR, et al. Validity and underrecording of diagnosis of COPD in the Danish National Patient Registry. Respir Med 2011;105:10631068.
19. Schemper M, Smith TL. A note on quantifying follow-up in studies of failure time. Control Clin Trials 1996;17:343346.
20. Aalen OO, Johansen S. An empirical transition matrix for non-homogeneous Markov chains based on censored observations. Scand J Stat 1978;5:141150.
21. Gerds TA, Scheike TH, Andersen PK. Absolute risk regression for competing risks: interpretation, link functions, and prediction. Stat Med 2012;31:39213930.
22. Lin DY, Wei LJ, Ying Z. Checking the Cox model with cumulative sums of martingale-based residuals. Biometrika 1993;80:557572.
23. Tian L, Zhao L, Wei LJ. Predicting the restricted mean event time with the subject’s baseline covariates in survival analysis. Biostatistics 2014;15:222233.
24. Petty TL. John Hutchinson’s mysterious machine revisited. Chest 2002;121:219S223S.
25. Godfrey MS, Jankowich MD. The vital capacity is vital: epidemiology and clinical significance of the restrictive spirometry pattern. Chest 2016;149:238251.
26. Woodruff PG, Barr RG, Bleecker E, Christenson SA, Couper D, Curtis JL, et al.; SPIROMICS Research Group. Clinical significance of symptoms in smokers with preserved pulmonary function. N Engl J Med 2016;374:18111821.
27. Leone N, Courbon D, Thomas F, Bean K, Jégo B, Leynaert B, et al. Lung function impairment and metabolic syndrome: the critical role of abdominal obesity. Am J Respir Crit Care Med 2009;179:509516.
28. Jackson P, Siddharthan T. The global significance of PRISm: how data from low- and middle-income countries link physiology to inflammation. Eur Respir J 2020;55:2000184.
29. Wijnant SRA, Lahousse L, Brusselle GG. The global significance of PRISm: how data from low- and middle-income countries link physiology to inflammation. Eur Respir J 2020;55:2000354.
30. Engström G, Lind P, Hedblad B, Wollmer P, Stavenow L, Janzon L, et al. Lung function and cardiovascular risk: relationship with inflammation-sensitive plasma proteins. Circulation 2002;106:25552560.
31. Lange P, Groth S, Kastrup J, Mortensen J, Appleyard M, Nyboe J, et al. Diabetes mellitus, plasma glucose and lung function in a cross-sectional population study. Eur Respir J 1989;2:1419.
32. Perret JL, Lodge CJ, Lowe AJ, Johns DP, Thompson BR, Bui DS, et al.; TAHS investigators. Childhood pneumonia, pleurisy and lung function: a cohort study from the first to sixth decade of life. Thorax 2020;75: 2837.
33. Svanes C, Sunyer J, Plana E, Dharmage S, Heinrich J, Jarvis D, et al. Early life origins of chronic obstructive pulmonary disease. Thorax 2010;65:1420.
34. Agustí A, Noell G, Brugada J, Faner R. Lung function in early adulthood and health in later life: a transgenerational cohort analysis. Lancet Respir Med 2017;5:935945.
35. Vasquez MM, Zhou M, Hu C, Martinez FD, Guerra S. Low lung function in young adult life is associated with early mortality. Am J Respir Crit Care Med 2017;195:13991401.
36. Allinson JP, Hardy R, Donaldson GC, Shaheen SO, Kuh D, Wedzicha JA. Combined impact of smoking and early-life exposures on adult lung function trajectories. Am J Respir Crit Care Med 2017;196:10211030.
37. Lange P. Development and prognosis of chronic obstructive pulmonary disease with special reference to the role of tobacco smoking. An epidemiologic study. Dan Med Bull 1992;39:3048.
Comments Post a Comment

New User Registration

Not Yet Registered?
Benefits of Registration Include:
 •  A Unique User Profile that will allow you to manage your current subscriptions (including online access)
 •  The ability to create favorites lists down to the article level
 •  The ability to customize email alerts to receive specific notifications about the topics you care most about and special offers
American Journal of Respiratory and Critical Care Medicine

Click to see any corrections or updates and to confirm this is the authentic version of record